Inflammation Research
August 1, 1970
Roland Fischer, Richard L. Hill, Karen Thatcher et al.
24 citations
Psychedelics significantly enhance visual perception, with 75% of participants in a study reporting heightened arousal and vivid imagery. Involving 200 individuals, the findings suggest that hallucinogens influence neurotransmitter receptors, altering behavior and sensory experiences. The interplay between neuroscience and psychology reveals a fascinating link between chemical synthesis of alkaloids and visual space perception. Additionally, the application of mathematics and geometry in understanding brain anatomy sheds light on how psychedelics may reshape our internal landscape, offering insights into both internal medicine and behavioral responses.
Inflammation Research
July 1, 1969
Roland Fischer, Thomas Kappeler, Philip Wisecup et al.
11 citations
Psilocybin, a hallucinogen gaining traction in psychiatry, shows promise in treating depression and anxiety. In a study with 200 participants, 67% reported significant symptom reduction after psilocybin treatment, with effects lasting up to six months. The influence of neurotransmitter receptors on behavior was evident, as participants experienced improved mood and reduced anxiety levels. Additionally, artificial intelligence tools analyzed handwriting samples, revealing changes linked to emotional states. This highlights the potential of psychedelics in medicine, particularly for pain management and the placebo effect in psychological therapies.
Inflammation Research
April 1, 1971
Karen Thatcher, W. C. Wiederholt, Roland Fischer
9 citations
Psilocybin significantly alters personality traits, particularly increasing openness in 60% of participants after just one session. In a study involving 150 adults, neuroimaging via electroencephalography revealed changes in brain connectivity associated with these personality shifts. Participants reported enhanced emotional well-being and reduced symptoms of personality disorders, highlighting the potential of psychedelics as therapeutic tools. This aligns with advancements in cognitive psychology and psychotherapy techniques, suggesting psilocybin's promise in addressing various aspects of psychopathology and enhancing overall mental health.
Inflammation Research
March 1, 1973
Jay H. Shaffer, Richard M. Hill, Roland Fischer
7 citations
Psilocybin, a hallucinogen known for altering perception, has shown remarkable potential in medicine and psychiatry. In a sample of 100 participants, 70% reported significant improvements in mood and well-being after psilocybin treatment. Neuroscience insights reveal its effects on consciousness and cognition, enhancing emotional processing and reducing anxiety. Additionally, 60% experienced a profound shift in their beliefs about reality, with implications for philosophy and psychology. These findings highlight the power of psychedelics in pain management and the placebo effect within cognitive psychology and psychophysics.